Yonglong Jin

612 total citations
29 papers, 473 citations indexed

About

Yonglong Jin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Yonglong Jin has authored 29 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Yonglong Jin's work include MicroRNA in disease regulation (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Glioma Diagnosis and Treatment (3 papers). Yonglong Jin is often cited by papers focused on MicroRNA in disease regulation (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Glioma Diagnosis and Treatment (3 papers). Yonglong Jin collaborates with scholars based in China, Japan and United Kingdom. Yonglong Jin's co-authors include Yunqi Jiang, Libo Jiang, Jian Dong, Xiguang Liu, Xinlei Wu, Xiangyang Wang, Wenjing Xiao, Quan Wang, Zhenhua Feng and Wenhao Zheng and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Gene.

In The Last Decade

Yonglong Jin

25 papers receiving 464 citations

Peers

Countries citing papers authored by Yonglong Jin

Since Specialization

Citations

This map shows the geographic impact of Yonglong Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonglong Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonglong Jin more than expected).

Fields of papers citing papers by Yonglong Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonglong Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonglong Jin. The network helps show where Yonglong Jin may publish in the future.

Co-authorship network of co-authors of Yonglong Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Yonglong Jin. A scholar is included among the top collaborators of Yonglong Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonglong Jin. Yonglong Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case Report: Multimodal management of a rare pediatric astroblastoma using proton beam therapy and Gamma Knife radiosurgery—a case report and literature review 2025 ·Frontiers in Oncology ·(unknown), Xinfa Wang, Weihai Ning, Jianfeng Liang, Yonglong Jin, Yuanyang Nie, Jie Wang, (unknown), Wei Wang, Jun Zhao, Jingjing Kong, Yang Lü, (unknown), Yan Zou, Masashi Mizumoto, Shosei Shimizu	0
2	Hesperidin enhanced anti-breast cancer effect and alleviated cisplatin induced nephrotoxicity through silk fibroin delivery system 2025 ·Toxicology and Applied Pharmacology ·Yonglong Jin, Nan Dong, Shosei Shimizu, Yinuo Li, (unknown), Hong Qiao, Xiguang Liu, Shuai Liu, Chuanlong Guo, Lijie Wang	1
3	Proton Beam Therapy for a Rare Anaplastic Pleomorphic Xanthoastrocytoma: Case Report and Literature Review 2024 ·International Journal of Particle Therapy ·Wei Han, Yonglong Jin, Jie Wang, John H. Zhang, (unknown), Zishen Wang, Wei Wang, Yinuo Li, Weiwei Wang, Lu Yang, Shosei Shimizu	0
4	Effective local control of a giant calvarial hemangioma in a child by proton beam therapy: A case report and literature review 2024 ·Experimental and Therapeutic Medicine ·Zhipeng Shen, Masashi Mizumoto, Yoshiko Oshiro, Yonglong Jin, Jie Wang, Shuyan Zhang, Chao Liu, Zishen Wang, Wei Wang, Yinuo Li, Weiwei Wang, Jun Zhao, (unknown)	2
5	A Novel Inhibitor of Poly(ADP-Ribose) Polymerase-1 Inhibits Proliferation of a BRCA-Deficient Breast Cancer Cell Line *via* the DNA Damage–Activated cGAS–STING Pathway 2024 ·Chemical Research in Toxicology ·Yonglong Jin, Lijie Wang, (unknown), Na Zhang, Shosei Shimizu, Wenjing Xiao, Chuanlong Guo, Xiguang Liu, Hongzong Si	1
6	Proton beam therapy in a patient with secondary glioblastoma (32 years after postoperative irradiation of medulloblastoma): case report and literature review 2024 ·Radiation Oncology ·Jiwei Bai, (unknown), Yonglong Jin, Jie Wang, (unknown), (unknown), (unknown), Wei Wang, (unknown), Weiwei Wang, Lu Yang, Shosei Shimizu	1
7	Regulation of Eukaryotic Translation Initiation Factor 4E as a Potential Anticancer Strategy 2023 ·Journal of Medicinal Chemistry ·Xintao Gao, Yonglong Jin, Wenyong Zhu, Xiaochen Wu, Jing Wang, Chuanlong Guo	3
8	Proton therapy (PT) combined with concurrent chemotherapy for locally advanced non-small cell lung cancer with negative driver genes 2023 ·Radiation Oncology ·Yonglong Jin, Shosei Shimizu, Yinuo Li, (unknown), Xiguang Liu, Hongzong Si, Hideyuki Sakurai, Wenjing Xiao	13
9	Hepatic cavernous hemangioma developed in non-small cell lung cancer patients after receiving Camrelizumab treatment: two case reports 2023 ·Frontiers in Oncology ·Yonglong Jin, Jinpeng Xu, (unknown), Lina Dong, Yang Sun, Lin Zhao, Wenjing Xiao	2
10	Inhibitory effect and mechanism of ‘Taizi Yangrong Decoction’on oral mucositis after radiotherapy for nasopharyngeal carcinoma in vivo and in vitro 2022 ·Yonglong Jin, Xiguang Liu, Jing Zhou, Lijie Wang, (unknown), Haijun Lu, Haijun Lu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
11	Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified 2021 ·Medicine ·Yonglong Jin, Wenjing Xiao, Xintong Wang, (unknown), Bo Li, Xiguang Liu	2
12	miR-199a-5p is involved in doxorubicin resistance of non-small cell lung cancer (NSCLC) cells 2020 ·European Journal of Pharmacology ·Yonglong Jin, Hui‐Yun Wang, (unknown), Hui Feng, Guanqun Wang, (unknown)	25
13	<p>LncRNA TTN-AS1 Regulates miR-524-5p and RRM2 to Promote Breast Cancer Progression</p> 2020 ·OncoTargets and Therapy ·Hui Feng, Qi Wang, Wenjing Xiao, (unknown), Yonglong Jin, (unknown)	17
14	<p>Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers</p> 2020 ·Drug Design Development and Therapy ·Yonglong Jin, (unknown), Xiguang Liu, Jing Zhou, Xintong Wang, Hui Feng, (unknown)	17
15	Targeting survivin sensitizes cervical cancer cells to radiation treatment 2020 ·Bioengineered ·Jing Zhou, Xiaojing Guo, (unknown), Liming Wang, Yonglong Jin	19
16	FGF10 Enhances Peripheral Nerve Regeneration via the Preactivation of the PI3K/Akt Signaling-Mediated Antioxidant Response 2019 ·Frontiers in Pharmacology ·(unknown), Rui Li, Duohui Li, Beini Wang, Yingfeng Lu, Peifeng Li, (unknown), Yonglong Jin, Xiao Ni, Yanqing Wu, Shengnan Yang, (unknown), Xiaokun Li, Jian Xiao, Jian Wang	39
17	Butein inhibits IL-1β-induced inflammatory response in human osteoarthritis chondrocytes and slows the progression of osteoarthritis in mice 2016 ·International Immunopharmacology ·Wenhao Zheng, Hui Zhang, Yonglong Jin, Quan Wang, Linwei Chen, Zhenhua Feng, Hua Chen, Yaosen Wu	70
18	Interspinous Spacer versus Traditional Decompressive Surgery for Lumbar Spinal Stenosis: A Systematic Review and Meta-Analysis 2014 ·PLoS ONE ·Aimin Wu, Yong Zhou, Qinglong Li, Xinlei Wu, Yonglong Jin, Peng Luo, Yong-Long Chi, Xiangyang Wang	64
19	A Systematic Review and Meta-Analysis of Unilateral versus Bilateral Pedicle Screw Fixation in Transforaminal Lumbar Interbody Fusion 2014 ·PLoS ONE ·(unknown), Xinlei Wu, Cong Xu, (unknown), Yonglong Jin, Lijun Wu, Xiangyang Wang, Huazi Xu, Naifeng Tian	19
20	Are circulating autoantibodies to ABCC3 transporter a potential biomarker for lung cancer? 2012 ·Journal of Cancer Research and Clinical Oncology ·Linlin Liu, Nian Liu, Baogang Liu, Yuan‐Han Yang, Qi Zhang, Weijing Zhang, (unknown), Yonglong Jin, Jia Guo, (unknown), Shilong Sun, Lining Miao, Jun Wei	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact